Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2003 1
2004 6
2005 3
2006 4
2008 5
2009 5
2010 5
2011 5
2012 5
2013 5
2014 2
2015 1
2016 1
2017 1
2019 1
2020 3
2021 3
2022 3
2023 6
2024 10
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis.
Al-Ibraheem A, Abdlkadir AS, Al-Adhami DA, Sathekge M, Bom HH, Ma'koseh M, Mansour A, Abdel-Razeq H, Al-Rabi K, Estrada-Lobato E, Al-Hussaini M, Matalka I, Abdel Rahman Z, Fanti S. Al-Ibraheem A, et al. Among authors: matalka i. Front Immunol. 2024 Sep 2;15:1424269. doi: 10.3389/fimmu.2024.1424269. eCollection 2024. Front Immunol. 2024. PMID: 39286245 Free PMC article.
Metabolic vulnerabilities in cancer: A new therapeutic strategy.
El-Tanani M, Rabbani SA, El-Tanani Y, Matalka II. El-Tanani M, et al. Among authors: matalka ii. Crit Rev Oncol Hematol. 2024 Sep;201:104438. doi: 10.1016/j.critrevonc.2024.104438. Epub 2024 Jul 6. Crit Rev Oncol Hematol. 2024. PMID: 38977145 Review.
Impact of exosome therapy on pancreatic cancer and its progression.
El-Tanani M, Nsairat H, Matalka II, Aljabali AAA, Mishra V, Mishra Y, Naikoo GA, Chava SR, Charbe NB, Tambuwala MM. El-Tanani M, et al. Among authors: matalka ii. Med Oncol. 2023 Jul 5;40(8):225. doi: 10.1007/s12032-023-02101-x. Med Oncol. 2023. PMID: 37405480 Free PMC article. Review.
Corrigendum to "Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer" [Life Sci., 329 (2023) 121964].
El-Tanani M, Platt-Higgins A, Nsairat H, Matalka II, Ahmed KA, Zhang SD, Alshaer W, Awidi A, Matchett KB, Aljabali AA, Mishra V, Serrano-Aroca Á, Tambuwala MM, Rudland PS. El-Tanani M, et al. Among authors: matalka ii. Life Sci. 2023 Oct 15;331:122075. doi: 10.1016/j.lfs.2023.122075. Epub 2023 Sep 10. Life Sci. 2023. PMID: 37696731 No abstract available.
75 results